Intelligence · Clinical Development
Pipeline search results
Programs matching “Bristol Myers Squibb” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 40 pipeline programs matching "Bristol Myers Squibb" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
BMS-986466
Bristol-Myers Squibb
Advanced Solid Tumors
1 trial -
BMS-986504
Bristol-Myers Squibb
Solid Tumors
1 trial -
Dasatinib
Bristol-Myers Squibb
Chronic Myeloid Leukemia
1 trial -
Deucravacitinib
Bristol-Myers Squibb
Alopecia Areata
1 trial -
Nivolumab
Bristol-Myers Squibb
Hepatocellular Carcinoma
1 trial -
Nivolumab
Bristol-Myers Squibb
Prostate Cancer
1 trial -
Relatlimab
Bristol-Myers Squibb
Neoplasms by Site
1 trial -
nivolumab
Bristol-Myers Squibb
Neoplasms by Site
1 trial -
vinflunine
Bristol-Myers Squibb
Transitional Cell Carcinoma
1 trial -
BMS-641988 (AR#2)
Bristol-Myers Squibb
Prostate Cancer
1 trial -
BMS-906024
Bristol-Myers Squibb
Cancer
1 trial -
BMS-986148
Bristol-Myers Squibb
Advanced Cancer
1 trial -
BMS-986202
Bristol-Myers Squibb
Psoriasis
1 trial -
BMS-986500
Bristol-Myers Squibb
Advanced Solid Tumor
1 trial -
CC-122
Bristol-Myers Squibb
Non-Hodgkin Lymphoma
1 trial -
Nivolumab
Bristol-Myers Squibb
Melanoma
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.